Gotham Asset Management’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.02M | Buy |
44,939
+12,011
| +36% | +$267K | ﹤0.01% | 1304 |
|
|
2025
Q4 | $852K | Sell |
32,928
-405
| -1% | -$9.63K | ﹤0.01% | 1310 |
|
|
2025
Q3 | $859K | Sell |
33,333
-8,829
| -21% | -$217K | ﹤0.01% | 1253 |
|
|
2025
Q2 | $1.01M | Sell |
42,162
-1,009
| -2% | -$25.4K | 0.01% | 1133 |
|
|
2025
Q1 | $1.07M | Sell |
43,171
-21,777
| -34% | -$521K | 0.01% | 987 |
|
|
2024
Q4 | $1.22M | Sell |
64,948
-25,965
| -29% | -$456K | 0.01% | 856 |
|
|
2024
Q3 | $1.37M | Buy |
90,913
+61,985
| +214% | +$1.06M | 0.01% | 833 |
|
|
2024
Q2 | $828K | Buy |
28,928
+15,387
| +114% | +$438K | 0.01% | 941 |
|
|
2024
Q1 | $396K | Sell |
13,541
-8,187
| -38% | -$252K | 0.01% | 1123 |
|
|
2023
Q4 | $733K | Sell |
21,728
-589
| -3% | -$17.2K | 0.01% | 872 |
|
|
2023
Q3 | $685K | Buy |
22,317
+3,203
| +17% | +$115K | 0.01% | 882 |
|
|
2023
Q2 | $766K | Sell |
19,114
-11,335
| -37% | -$469K | 0.02% | 847 |
|
|
2023
Q1 | $1.24M | Buy |
+30,449
| New | +$1.21M | 0.03% | 682 |
|
|
2022
Q4 | – | Sell |
-5,079
| Closed | -$270K | – | 1292 |
|
|
2022
Q3 | $270K | Buy |
5,079
+1,097
| +28% | +$61K | 0.01% | 1013 |
|
|
2022
Q2 | $232K | Sell |
3,982
-2,526
| -39% | -$165K | 0.01% | 1001 |
|
|
2022
Q1 | $497K | Sell |
6,508
-18,066
| -74% | -$1.2M | 0.02% | 808 |
|
|
2021
Q4 | $1.48M | Buy |
24,574
+4,198
| +21% | +$231K | 0.05% | 436 |
|
|
2021
Q3 | $1.14M | Buy |
20,376
+12,794
| +169% | +$737K | 0.05% | 454 |
|
|
2021
Q2 | $460K | Buy |
7,582
+301
| +4% | +$19.1K | 0.02% | 704 |
|
|
2021
Q1 | $510K | Sell |
7,281
-4,726
| -39% | -$338K | 0.02% | 677 |
|
|
2020
Q4 | $718K | Buy |
12,007
+137
| +1% | +$8.02K | 0.02% | 631 |
|
|
2020
Q3 | $714K | Sell |
11,870
-1,732
| -13% | -$101K | 0.02% | 643 |
|
|
2020
Q2 | $714K | Sell |
13,602
-46,637
| -77% | -$1.95M | 0.02% | 657 |
|
|
2020
Q1 | $2.02M | Buy |
60,239
+31,593
| +110% | +$1.31M | 0.06% | 409 |
|
|
2019
Q4 | $1.3M | Sell |
28,646
-22,270
| -44% | -$946K | 0.02% | 572 |
|
|
2019
Q3 | $1.94M | Buy |
50,916
+7,571
| +17% | +$302K | 0.03% | 461 |
|
|
2019
Q2 | $1.89M | Buy |
43,345
+35,137
| +428% | +$1.49M | 0.03% | 518 |
|
|
2019
Q1 | $312K | Buy |
+8,208
| New | +$320K | ﹤0.01% | 985 |
|
|
2015
Q2 | – | Sell |
-9,319
| Closed | -$828K | – | 1008 |
|
|
2015
Q1 | $828K | Buy |
+9,319
| New | +$946K | 0.01% | 624 |
|
|
2014
Q4 | – | Sell |
-6,946
| Closed | -$673K | – | 1020 |
|
|
2014
Q3 | $673K | Sell |
6,946
-2,540
| -27% | -$247K | 0.01% | 704 |
|
|
2014
Q2 | $871K | Buy |
+9,486
| New | +$722K | 0.01% | 675 |
|
Other funds holding PCRX
DPCM
VPM
VCM
